PMV Pharmaceuticals, Inc.
- Biotech or pharma, therapeutic R&D
At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer.
June 16-19, 2025
Boston Convention & Exhibition Center